SGMO
Sangamo Therapeutics Inc
NASDAQ: SGMO · HEALTHCARE · BIOTECHNOLOGY
$0.12
-10.24% today
Updated 2026-04-30
Market cap
$78.75M
P/E ratio
—
P/S ratio
1.99x
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$0 – $1
Volume
7.8M
Sangamo Therapeutics Inc (SGMO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.88M | $9.10M | $16.19M | $22.19M | $20.80M | $10.32M | $21.66M | $24.13M | $45.87M | $39.54M | $19.39M | $36.57M | $84.45M | $102.43M | $118.19M | $110.70M | $111.30M | $176.23M | $57.80M | $39.55M |
| Revenue growth (YoY) | — | +15.4% | +77.9% | +37.1% | -6.2% | -50.4% | +109.9% | +11.4% | +90.1% | -13.8% | -51.0% | +88.6% | +131.0% | +21.3% | +15.4% | -6.3% | +0.5% | +58.3% | -67.2% | -31.6% |
| Cost of revenue | $28.44M | $33.59M | $41.04M | $41.02M | $45.06M | $45.49M | $43.19M | $36.98M | $56.74M | $67.13M | $65.62M | $65.73M | $114.87M | $145.92M | $180.65M | $9.44M | $12.11M | $22.19M | $9.36M | $7.60M |
| Gross profit | $7.88M | $9.10M | $16.19M | $22.19M | $20.80M | $10.32M | $21.66M | $-12.85M | $-10.87M | $39.54M | $19.39M | $36.57M | $84.45M | $102.43M | $118.19M | $110.70M | $111.30M | $176.23M | $57.80M | $31.95M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -53.2% | -23.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 80.8% |
| R&D | $21.53M | $25.56M | $31.23M | $28.98M | $33.15M | $32.10M | $31.71M | $36.98M | $56.74M | $67.20M | $65.62M | $65.73M | $114.87M | $145.92M | $180.65M | $230.82M | $249.90M | $234.06M | $111.52M | $112.67M |
| SG&A | $7.09M | $8.31M | $10.33M | $12.61M | $12.59M | $14.04M | $12.14M | $13.80M | $15.68M | $19.20M | $26.33M | $27.20M | $46.74M | $61.69M | $67.10M | $63.22M | $62.68M | $61.17M | $44.73M | $34.89M |
| Operating income | $-20.73M | $-24.77M | $-25.38M | $-19.40M | $-24.93M | $-35.82M | $-22.20M | $-26.71M | $-26.78M | $-46.86M | $-72.56M | $-56.36M | $-77.15M | $-105.18M | $-129.55M | $-183.34M | $-201.28M | $-274.00M | $-103.97M | $-108.00M |
| Operating margin | -262.9% | -272.3% | -156.8% | -87.4% | -119.9% | -347.1% | -102.5% | -110.7% | -58.4% | -118.5% | -374.2% | -154.1% | -91.4% | -102.7% | -109.6% | -165.6% | -180.8% | -155.5% | -179.9% | -273.1% |
| EBITDA | $-20.73M | $-24.77M | $-24.85M | $-18.83M | $-24.26M | $-35.17M | $-21.54M | $-26.08M | $-26.23M | $-45.87M | $-71.56M | $-54.86M | $-74.79M | $-95.57M | $-116.18M | $-165.70M | $-180.72M | $-96.80M | $-89.09M | $-100.40M |
| EBITDA margin | -262.9% | -272.3% | -153.5% | -84.9% | -116.6% | -340.9% | -99.5% | -108.1% | -57.2% | -116.0% | -369.1% | -150.0% | -88.6% | -93.3% | -98.3% | -149.7% | -162.4% | -54.9% | -154.1% | -253.8% |
| EBIT | $-20.04M | $-22.90M | $-25.38M | $-19.40M | $-24.93M | $-35.82M | $-22.20M | $-26.65M | $-26.78M | $-46.86M | $-72.56M | $-56.36M | $-77.15M | $-105.18M | $-129.55M | $-183.34M | $-201.28M | $-118.99M | $-98.45M | $-108.00M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $22.27M | $23.00M | $9.43M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.86M | $-21.48M | $-24.30M | $-18.59M | $-24.85M | $-35.75M | $-22.26M | $-26.62M | $-26.42M | $-40.70M | $-71.66M | $-54.57M | $-68.33M | $-75.82M | $-121.12M | $-178.30M | $-192.28M | $-257.83M | $-97.94M | $-122.93M |
| Net income growth (YoY) | — | -20.2% | -13.1% | +23.5% | -33.7% | -43.8% | +37.7% | -19.6% | +0.8% | -54.1% | -76.1% | +23.8% | -25.2% | -11.0% | -59.8% | -47.2% | -7.8% | -34.1% | +62.0% | -25.5% |
| Profit margin | -226.6% | -236.1% | -150.1% | -83.8% | -119.5% | -346.4% | -102.8% | -110.3% | -57.6% | -102.9% | -369.6% | -149.2% | -80.9% | -74.0% | -102.5% | -161.1% | -172.8% | -146.3% | -169.4% | -310.8% |